BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37170014)

  • 1. Involvement of the non-active site Residues in the Catalytic Activity of NDM-4 Metallo beta-lactamase.
    Verma J; Jain D; Panda AP; Kant S; Kumar G; Ghosh AS
    Protein J; 2023 Aug; 42(4):316-326. PubMed ID: 37170014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E152A substitution drastically affects NDM-5 activity.
    Kumar G; Issa B; Kar D; Biswal S; Ghosh AS
    FEMS Microbiol Lett; 2017 Feb; 364(3):. PubMed ID: 28087620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamic acid at position 152 and serine at position 191 are key residues required for the metallo-β-lactamase activity of NDM-7.
    Kumar G; Issa B; Biswal S; Jain D; Bhattacharjee A; Ghosh AS
    Int J Antimicrob Agents; 2020 Jan; 55(1):105824. PubMed ID: 31634553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Non-Active-Site Residue Trp-93 in the Function and Stability of New Delhi Metallo-β-Lactamase 1.
    Khan AU; Rehman MT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):356-60. PubMed ID: 26525789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.
    Makena A; Brem J; Pfeffer I; Geffen RE; Wilkins SE; Tarhonskaya H; Flashman E; Phee LM; Wareham DW; Schofield CJ
    J Antimicrob Chemother; 2015 Feb; 70(2):463-9. PubMed ID: 25324420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of conserved residues in the catalytic activity of NDM-1: an approach involving site directed mutagenesis and molecular dynamics.
    Ali A; Kumar R; Iquebal MA; Jaiswal S; Kumar D; Khan AU
    Phys Chem Chem Phys; 2019 Aug; 21(32):17821-17835. PubMed ID: 31373340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of New Delhi metallo-β-lactamase (NDM) in the clinic: Effects of NDM mutations on stability, zinc affinity, and mono-zinc activity.
    Cheng Z; Thomas PW; Ju L; Bergstrom A; Mason K; Clayton D; Miller C; Bethel CR; VanPelt J; Tierney DL; Page RC; Bonomo RA; Fast W; Crowder MW
    J Biol Chem; 2018 Aug; 293(32):12606-12618. PubMed ID: 29909397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and
    Moreira JS; Galvão DS; Xavier CFC; Cunha S; Pita SSDR; Reis JN; Freitas HF
    J Biomol Struct Dyn; 2022; 40(24):14223-14235. PubMed ID: 34766882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of purified New Delhi metallo-β-lactamase-1.
    Thomas PW; Zheng M; Wu S; Guo H; Liu D; Xu D; Fast W
    Biochemistry; 2011 Nov; 50(46):10102-13. PubMed ID: 22029287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-active site mutation (Q123A) in New Delhi metallo-β-lactamase (NDM-1) enhanced its enzyme activity.
    Ali A; Azam MW; Khan AU
    Int J Biol Macromol; 2018 Jun; 112():1272-1277. PubMed ID: 29454953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in passive residues modulate 3D-structure of NDM (New Delhi metallo-β-lactamase) protein that endue in drug resistance: a MD simulation approach.
    Kumar R
    J Biomol Struct Dyn; 2022; 40(19):9492-9508. PubMed ID: 34034624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential substrate binding conformation of β-lactams and insight into the broad spectrum of NDM-1 activity.
    Yuan Q; He L; Ke H
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5157-63. PubMed ID: 22825119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of NDM-19, a novel variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity under zinc-limited conditions, in Switzerland.
    Mancini S; Keller PM; Greiner M; Bruderer V; Imkamp F
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114851. PubMed ID: 31285120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asp120Asn mutation impairs the catalytic activity of NDM-1 metallo-β-lactamase: experimental and computational study.
    Chen J; Chen H; Zhu T; Zhou D; Zhang F; Lao X; Zheng H
    Phys Chem Chem Phys; 2014 Apr; 16(14):6709-16. PubMed ID: 24584846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NDM-8 metallo-β-lactamase in a multidrug-resistant Escherichia coli strain isolated in Nepal.
    Tada T; Miyoshi-Akiyama T; Dahal RK; Sah MK; Ohara H; Kirikae T; Pokhrel BM
    Antimicrob Agents Chemother; 2013 May; 57(5):2394-6. PubMed ID: 23459485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of New Delhi metallo-β-lactamase gene (NDM-1) from a clinical isolate of Acinetobacter junii in China.
    Zhou Z; Guan R; Yang Y; Chen L; Fu J; Deng Q; Xie Y; Huang Y; Wang J; Wang D; Liao C; Gong S; Xia H
    Can J Microbiol; 2012 Jan; 58(1):112-5. PubMed ID: 22181044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
    Muteeb G; Alsultan A; Farhan M; Aatif M
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
    Palacios AR; Mojica MF; Giannini E; Taracila MA; Bethel CR; Alzari PM; Otero LH; Klinke S; Llarrull LI; Bonomo RA; Vila AJ
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches.
    Muteeb G; Rehman MT; AlAjmi MF; Aatif M; Farhan M; Shafi S
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).
    Shen B; Yu Y; Chen H; Cao X; Lao X; Fang Y; Shi Y; Chen J; Zheng H
    PLoS One; 2013; 8(5):e62955. PubMed ID: 23675445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.